gMendel’s Post

The key trends in the conversations during #bioceo24 (Bio CEO & Investor Conference) in New York were #AI in #healthcare. A clear shift in life sciences as well as how genomics are accelerating R&D. Genesis Healthcare was also present during the event, with our Chief Innovation Officer introducing GenesisGaia, our genomic R&D platform powered by generative AI. Read more about GenesisGaia at www.genesisgaia.com #genesisgaia #genesishealthcare #genelife #genesispro #genetics #biotech #techbio #genomics #data #genomicdata #Japan #asia #health #healthcare #biotech #lifesciences #RD #platform #genomicplatform  

In the world of biology, phenomics has revolutionized our understanding of plants, allowing us to analyze complex traits and uncover new ways to improve crop resilience and yield. The impact of this approach has been profound, helping us tackle challenges in food security and environmental sustainability. But what if we could apply the same principles to human health? Imagine using data-driven techniques to explore the intricate connections between our genes, environment, lifestyle, and clinical outcomes. Just as phenomics has enabled us to decode the secrets of plant biology, it's now paving the way for groundbreaking advancements in medicine. In healthcare, phenomics offers the potential to understand diseases at a much deeper level, enabling personalized treatment plans, early diagnosis, and even the prevention of conditions before they manifest. By leveraging vast amounts of clinical and genomic data, we can identify patterns that were previously invisible, leading to better patient outcomes and more efficient healthcare systems. The rapid development of research fields like multi-omics and artificial intelligence (AI) has enabled us to acquire and analyze multi-dimensional big data on human phenomes, offering a revolutionary strategy for discovering new risk factors, diagnostic biomarkers, and precision therapies. Phenomics provides us with tools that surpass conventional methods in achieving precision medicine, and here's why: - Richer Information: The data from patients' phenomes is multi-dimensional, providing a wealth of information far beyond what genomic data alone can offer. This depth allows for a more comprehensive understanding of individual health profiles. - Cross-Scale Correlations: Phenomics enables us to uncover correlations among various phenomic parameters—across scales and dimensions—that were previously invisible. Understanding these correlations can reveal the underlying mechanisms of diseases, leading to more effective treatments. - Data-Driven Discovery: By leveraging the power of AI and big data, phenomics-based studies are inherently data-driven. This not only enhances the efficiency of research but also increases the likelihood of making novel discoveries that could transform healthcare. As we continue to bridge the gap between these two fields, the promise of phenomics in healthcare becomes not just a possibility but a reality that could transform the future of medicine. Let’s embrace this interdisciplinary approach to unlock new possibilities for human health, just as we have for plants. #Phenomics #HealthcareInnovation #DataScience #PrecisionMedicine #FutureOfHealth

Wonderfully, some of UGenome AI's distributed team from 5 continents was able to meet in person in San Diego, California from June 3-5. Emma Bardin Peter Bannister Jayden Lee, EMBA, PharmD, BCACP Zachary S. Brooks, PhD, EMBA (pictured above). UGenome AI was also able to meet with one of its advisors Jack Florio. Not pictured but always appreciated for their contributions to UGenome AI's success include: Laura Hong, Ph.D. Anishek Kamal, Shay Stautz, Alan Thomas Kohler, PhD, Ayse ULGEN, PhD, MGM, Neha R Parate, Husna Rahim, Maisam Jafri, Corina Blanas, Ben Stansfield, Jennifer Tovar, Komal Sharma, Panashe Nyengera, Thelma Mapangera, Wayne Mazonde, Bettina Dube, Navya Brinda, Niharika Koppolu, Ansha Gupta, Kate Lee, Partha Koundinya Panguluri, Nazhou(Joe) LIU, Tony Caldwell, April Wurster, Randall Stafford, Randall Stafford, Ezra Smith, Gondy Leroy, Ritu Pandey, Wahbi El-Bouri, Xinyu (Eric) Wang, Dr. Adrijana Kekic #sandiego, #bullpen, #ugenome, #ugenomeai, #pharmacogenomics, #pharmacogenetics, #bioinformatics, #genetics, #dna, #research, #genomics, #medicine, #drugdiscovery, #datascience, #biostatistics, #pharma, #genomicmedicine, #sequencing, #dataanalysis, #precisionmedicine

Nygen Insights is built to enhance the accuracy and impact of your research. 𝗢𝘂𝗿 𝗟𝗟𝗠 𝗮𝘂𝗴𝗺𝗲𝗻𝘁𝗲𝗱 𝗸𝗻𝗼𝘄𝗹𝗲𝗱𝗴𝗲 𝗱𝗶𝘀𝘁𝗶𝗹𝗹𝗮𝘁𝗶𝗼𝗻 𝗳𝗲𝗮𝘁𝘂𝗿𝗲 is designed to derive insights with your specific data, helping you accelerate discoveries. With Nygen Insights, you can: - Achieve 𝗵𝗶𝗴𝗵-𝗰𝗼𝗻𝗳𝗶𝗱𝗲𝗻𝗰𝗲 𝗰𝗲𝗹𝗹 𝗮𝗻𝗻𝗼𝘁𝗮𝘁𝗶𝗼𝗻𝘀 for clearer results. - Perform 𝗶𝗻-𝗱𝗲𝗽𝘁𝗵 disease analysis with 𝗱𝗲𝘁𝗮𝗶𝗹𝗲𝗱 𝗰𝗲𝗹𝗹𝘂𝗹𝗮𝗿 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀. - Generate 𝗰𝘂𝘀𝘁𝗼𝗺 𝗯𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 tailored to your data. 𝗛𝗮𝘃𝗲 𝘆𝗼𝘂 𝘀𝗶𝗴𝗻𝗲𝗱 𝘂𝗽 𝗳𝗼𝗿 𝗳𝗿𝗲𝗲 𝗼𝗻 𝗡𝘆𝗴𝗲𝗻 𝘆𝗲𝘁? #NygenAnalytics #LLM #Biotech #AI

The Role of Genomics in Modern Healthcare Genomics is at the forefront of a new era in healthcare, where personalized medicine is becoming the norm. By understanding the genetic makeup of individuals, we can develop more targeted and effective treatments for a variety of diseases. At Genomac Holdings, we're leveraging the power of genomics to drive innovation in healthcare, from research to real-world applications. Our work is not just about advancing science; it's about making a tangible difference in people's lives. As we continue to explore the potential of genomics, we're excited to share our findings and collaborate with global stakeholders to push the boundaries of what's possible in healthcare. #Genomics #HealthcareInnovation #PersonalizedMedicine #Biotech #Innovation

🧬 Delving into the world of Single-cell Data Analysis! Grateful for the eye-opening insights gained from the recent webinar hosted by DrOmics labs Private Limited. on "Unveiling Mysteries: The Basics of Single-cell Data Analysis." In today's era of precision medicine and personalized therapies, understanding single-cell data is paramount. It's the gateway to unlocking profound insights into cellular heterogeneity and disease mechanisms, paving the way for groundbreaking advancements in healthcare. Learning from the expertise of Yogesh Kumar (Ph.D.) was invaluable! Let's harness this knowledge to drive innovation and transform lives. #singlecellanalysis #genetics #rprogramming

Elucidata x Almaden Genomics 🤝 📢 We are thrilled to announce that Elucidata is now partnering with Almaden Genomics, bringing together Polly's #dataharmonization capabilities with g.nome®. This partnership not only marks a significant advancement in #omics data science but also sets a new pace for #drugdiscovery processes. 💊🧬 🔗By combining our strengths, we're aiming to smash through the barriers of data silos, ensuring that the insights we generate are not just richer but more actionable. This is about speeding up the journey from research to treatment, making sure that groundbreaking therapies reach patients sooner. We're proud to lead this charge, transforming the landscape of #lifesciences. ✨ Keen to dive deeper into this transformative alliance? Here's the scoop- https://lnkd.in/dQDFfpCh Abhishek Jha Swetabh Pathak David Gascoigne

Have you wondered how AI can help your research? Here is one way. Saves months of work for single-cell analysis.

UGenome Values 1. Curiosity. Learners & Teachers. We learn and teach with joy and respect for the complexities of understanding new phenomena. 2. Empathy. Respect for your complicated lives We respect that humans have complicated lives. 3. Trust We are honest and transparent with what we believe our capacities are. We believe in constructive candor. 4. Diversity We celebrate diversity in people and perspectives and advocate for diversity in data to improve the robustness and generalizability of actionable insights. 5. Adaptability We embrace change as an opportunity for growth to better meet the needs of our customers, healthcare practitioners, and patients. 6. Innovation We are driven by a quest to help others and innovate by cultivating curiosity and collaboration to try something new. 7. Excellence We commit to upholding rigorous standards in delivering high-quality work and creating best-in-class tools/products. #ugenome, #ugenomeai, #ugenomebiotech, #bioinformatics, #biotech, #genetics, #science, #dna, #research, #genomics, #medicine, #immunology, #drugdiscovery, #datascience, #lifesciences, #biostatistics, #health, #pharma, #genomeannotation, #pharmacogenomics, #pharmacogenetics, #genomicmedicine, #sequencing, #dataanalysis, #machinelearning, #precisionmedicine, #metagenomics,